Skip to content
  • Tuesday, 29 September 2026
  • 4:37 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • AvenCell Therapeutics Unveils Promising Early Data for Switchable Allogeneic CAR-T Therapy in Relapsed/Refractory AML at EHA 2026
Pharmaceutical R&D

AvenCell Therapeutics Unveils Promising Early Data for Switchable Allogeneic CAR-T Therapy in Relapsed/Refractory AML at EHA 2026

Teuku Ryan Jun 16, 2026 0

AvenCell Therapeutics presented updated results for its CAR-T cell blood cancer therapy at EHA 2026. The European Hematology Association (EHA)…

Read More
The Hypothalamic Protein Menin Serves as a Critical Regulator of Systemic Aging and Cognitive DeclineScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921The Mystery of the Vanished Seychelles Crocodiles Solved: Genetic Analysis Reveals Westernmost Outpost of the Saltwater CrocodileLungs Identified as a Primary Site of Blood Production in Humans Challenging Decades of Medical Dogma
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Tolerance Bio Secures Exclusive Global Rights Outside Japan for Tanabe Pharma Anti-IL-33 Monoclonal Antibody TLB-33 in Landmark $560m DealUnprecedented Genetic Study Reveals Explosive Growth Rates and Origins of Chronic Myeloid Leukemia Years Before DiagnosisAs the dream of the autonomous clinical trial dawns, agent supervision is today’s human jobNew Research Identifies Peripheral Immune Pathway as a Critical Driver of Alzheimer’s Disease Neurodegeneration
YOU MAY HAVE MISSED
Pharmaceutical R&D
Tolerance Bio Secures Exclusive Global Rights Outside Japan for Tanabe Pharma Anti-IL-33 Monoclonal Antibody TLB-33 in Landmark $560m Deal
Teuku Ryan Sep 29, 2026
Stem Cell & Regenerative Medicine
Unprecedented Genetic Study Reveals Explosive Growth Rates and Origins of Chronic Myeloid Leukemia Years Before Diagnosis
Dwi Wanna Sep 29, 2026
Laboratory Automation & Robotics
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
Lana Keisha Sep 29, 2026
Neuroscience & Brain Research
New Research Identifies Peripheral Immune Pathway as a Critical Driver of Alzheimer’s Disease Neurodegeneration
Rifan Muazin Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ